» Articles » PMID: 33660524

Prediction of Death After Noncardiac Surgery: Potential Advantage of Using High-Sensitivity Troponin T As a Continuous Variable

Overview
Date 2021 Mar 4
PMID 33660524
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background Increased high-sensitivity cardiac troponin T (hs-cTnT) above the upper reference limit (URL) after noncardiac surgery identifies patients at risk for mortality. Prior studies have not analyzed hs-cTnT as a continuous variable or probed age- and sex-specific URLs. This study compared the prediction of 30-day mortality using continuous postoperative hs-cTnT levels to the use of the overall URL and age- and sex-specific URLs. Methods and Results Patients (876) >40 years of age who underwent noncardiac surgery were included. Hs-cTnT was measured on postoperative day 1. Cox proportional hazards models were used to compare associations between 30-day mortality and using hs-cTnT as a continuous variable, or above the overall or age- and sex-specific URLs. Comparisons were performed by the area under the receiver operating characteristic curve analysis. Mortality was 4.2%. For each 1 ng/L increase in postoperative hs-cTnT, there was a 0.3% increase in mortality (<0.001). Patients with postoperative hs-cTnT >14 ng/L were 37% of the cohort, while those above age- and sex-specific URLs were 25.3%. Both manifested higher mortality (hazard ratio [HR], 3.19; 95% CI, 1.20-8.49; =0.020) and (HR, 2.76; =0.009) than those with normal levels. The area under receiver operating characteristic curve was 0.89 using hs-cTnT as a continuous variable, 0.87 for age- and sex-specific URLs, and 0.86 for the overall URL. Conclusions Hs-cTnT as a continuous variable was independently associated with 30-day mortality and had the highest accuracy. Hs-cTnT elevations using overall and/or age- and sex-specific URLs were also associated with higher mortality.

Citing Articles

Association between cardiac troponin testing at scheduled admission and mortality in patients with comorbidities.

Oh A, Lee S, Park J, Choi D, Yang K Ann Transl Med. 2023; 11(1):7.

PMID: 36760262 PMC: 9906211. DOI: 10.21037/atm-22-3681.


Prediction of Death After Noncardiac Surgery: Potential Advantage of Using High-Sensitivity Troponin T as a Continuous Variable.

Machado M, Rodrigues F, Nakazone M, Martin D, Sabbag A, Grigolo I J Am Heart Assoc. 2021; 10(6):e018008.

PMID: 33660524 PMC: 8174224. DOI: 10.1161/JAHA.120.018008.

References
1.
Weber M, Luchner A, Seeberger M, Manfred S, Mueller C, Liebetrau C . Incremental value of high-sensitive troponin T in addition to the revised cardiac index for peri-operative risk stratification in non-cardiac surgery. Eur Heart J. 2012; 34(11):853-62. DOI: 10.1093/eurheartj/ehs445. View

2.
Gore M, Seliger S, deFilippi C, Nambi V, Christenson R, Hashim I . Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. J Am Coll Cardiol. 2014; 63(14):1441-8. PMC: 3984900. DOI: 10.1016/j.jacc.2013.12.032. View

3.
Thygesen K, Alpert J, Jaffe A, Chaitman B, Bax J, Morrow D . Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018; 138(20):e618-e651. DOI: 10.1161/CIR.0000000000000617. View

4.
Devereaux P, Duceppe E, Guyatt G, Tandon V, Rodseth R, Biccard B . Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial. Lancet. 2018; 391(10137):2325-2334. DOI: 10.1016/S0140-6736(18)30832-8. View

5.
Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe A, Katus H . Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2009; 56(2):254-61. DOI: 10.1373/clinchem.2009.132654. View